The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[2-(2-Oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamido]-benzoic Acid ID: ALA3590511
Chembl Id: CHEMBL3590511
PubChem CID: 1081530
Max Phase: Preclinical
Molecular Formula: C16H12N2O4S
Molecular Weight: 328.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Cn1c(=O)sc2ccccc21)Nc1ccc(C(=O)O)cc1
Standard InChI: InChI=1S/C16H12N2O4S/c19-14(17-11-7-5-10(6-8-11)15(20)21)9-18-12-3-1-2-4-13(12)23-16(18)22/h1-8H,9H2,(H,17,19)(H,20,21)
Standard InChI Key: NLXIKGNWIULWHU-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 328.35Molecular Weight (Monoisotopic): 328.0518AlogP: 2.40#Rotatable Bonds: 4Polar Surface Area: 88.40Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.16CX Basic pKa: ┄CX LogP: 2.42CX LogD: -0.64Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.77Np Likeness Score: -1.85
References 1. Moriya J, Takeuchi K, Tai K, Arai K, Kobayashi N, Yoneda N, Fukunishi Y, Inoue A, Kihara M, Murakami T, Chiba K, Shimada I.. (2015) Structure-Based Development of a Protein-Protein Interaction Inhibitor Targeting Tumor Necrosis Factor Receptor-Associated Factor 6., 58 (14): [PMID:26132273 ] [10.1021/acs.jmedchem.5b00778 ]